CBL — Casitas B-lineage Lymphoma
Overview
Mermaid diagram (expand to render)
Cbl Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
CBL (Casitas B-lineage Lymphoma) encodes a RING-type E3 ubiquitin ligase that serves as a critical negative regulator of receptor tyrosine kinase (RTK) signaling. Originally identified as an oncogene, CBL plays essential roles in neuronal development, synaptic plasticity, and cellular homeostasis. Germline mutations in CBL cause a spectrum of developmental disorders collectively termed CBL syndrome, which includes features of Noonan syndrome and increased risk of myeloproliferative disorders. [@cbl2008]
<div class="infobox infobox-gene"> [@cbl2014]
<table> [@cbl2010]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Casitas B-lineage Lymphoma</th></tr> [@neuronal2013]
<tr><td><strong>Gene Symbol</strong></td><td>CBL</td></tr> [@cbl2015]
<tr><td><strong>Full Name</strong></td><td>Casitas B-lineage Lymphoma</td></tr> [@jmml2012]
<tr><td><strong>Chromosome</strong></td><td>11q23.3</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[867](https://www.ncbi.nlm.nih.gov/gene/867)</td></tr>
<tr><td><strong>OMIM</strong></td><td>[165360](https://www.omim.org/entry/165360)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000110395</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P22681](https://www.uniprot.org/uniprot/P22681)</td></tr>
<tr><td><strong>Protein Class</strong></td><td>RING-type E3 ubiquitin ligase</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>CBL Syndrome, Noonan Syndrome-like, Myeloproliferative Disorders</td></tr>
</table>
</div>
Molecular Biology and Biochemistry
Protein Structure
CBL is a 906-amino acid protein with multiple functional domains:
- RING Finger Domain (aa 380-420): Catalytic domain that facilitates ubiquitin transfer
- TKB Domain (aa 23-377): Tyrosine kinase-binding domain recognizing phosphorylated substrates
- Linker Region: Connects TKB and RING domains, regulatory function
- C-terminal Proline-Rich Region: Mediates protein-protein interactions with SH3 domain-containing proteins
- UEV Domain: Ubiquitin-conjugating enzyme variant, substrate recognition
E3 Ubiquitin Ligase Function
CBL functions as a RING-type E3 ubiquitin ligase with the following substrate targets:
| Substrate | Function | Disease Relevance |
|-----------|----------|-------------------|
| EGFR | RTK signaling | Cancer |
| FLT3 | Hematopoiesis | Myeloproliferation |
| KIT | Stem cell factor receptor | Mastocytosis |
| VEGFR2 | Angiogenesis | Vascular disorders |
| SRC-family kinases | Signal transduction | Multiple |
Ubiquitination Types
CBL mediates multiple types of ubiquitination:
- K63-linked polyubiquitination: Signaling scaffold assembly
- K48-linked polyubiquitination: Proteasomal degradation
- Monoubiquitination: Receptor internalization
Expression Pattern
Brain Expression
CBL is expressed throughout the central nervous system:
- [Neurons](/entities/neurons): High expression in pyramidal neurons of [cortex](/brain-regions/cortex) and [hippocampus](/brain-regions/hippocampus)
- Glia: Moderate expression in [astrocytes](/entities/astrocytes) and [microglia](/cell-types/microglia-neuroinflammation)
- Development: Critical expression during embryonic neurodevelopment
Cellular Compartmentalization
In neurons, CBL localizes to:
- Postsynaptic densities
- [Dendritic spines](/cell-types/dendritic-spines)
- Growth cones
- Somatic cytoplasm
Physiological Functions
Receptor Tyrosine Kinase Regulation
CBL negatively regulates RTK signaling through:
Direct binding to activated RTKs via TKB domain
Ubiquitination of receptors for degradation
Endocytosis promotion via monoubiquitination
Lysosomal targeting of ubiquitinated receptorsSynaptic Plasticity
At synapses, CBL modulates:
- AMPA receptor trafficking and stability
- [NMDA receptor](/entities/nmda-receptor) subunit composition
- Synaptic scaling in response to activity
- [Long-term potentiation](/mechanisms/long-term-potentiation) (LTP) formation
Neuronal Development
During development, CBL regulates:
- Neuronal migration
- Axon guidance
- Dendrite morphogenesis
- Synapse formation
Disease Associations
CBL Syndrome (CBL-C, CBL-E)
Germline CBL mutations cause a multisystem disorder:
| Feature | Frequency | Description |
|---------|-----------|-------------|
| Developmental delay | 100% | Variable intellectual disability |
| Facial dysmorphism | 90% | Characteristic Noonan-like features |
| Cardiac defects | 70% | Pulmonic stenosis, septal defects |
| Cryptorchidism | 60% | Male genital anomalies |
| Hypotonia | 50% | Neonatal muscle weakness |
| Myeloproliferation | 40% | Juvenile myelomonocytic leukemia |
| Lentigines | 35% | Multiple nevi, LEOPARD features |
Noonan Syndrome-like Disorder
- Phenotypic overlap with RASopathies
- Variable expressivity
- Possible mosaicism in some cases
Neurological Manifestations
- Intellectual disability: Variable severity
- Autism spectrum features: Social communication deficits
- Seizures: In some patients
- Peripheral neuropathy: Rare
Cancer Predisposition
CBL acts as a tumor suppressor:
- Myeloid malignancies: JMML, AML
- Solid tumors: Renal cell carcinoma
- Mechanism: Haploinsufficiency + second hit
Mechanisms of Neurodegeneration
Altered RTK Signaling
CBL mutations lead to:
- Enhanced growth factor signaling
- Increased neuronal survival (potentially beneficial)
- Aberrant development (during critical periods)
Synaptic Dysfunction
- Impaired AMPA receptor endocytosis
- Altered NMDA receptor signaling
- Disrupted synaptic scaling
- Potential for excitotoxicity
ER Stress
- Accumulation of misfolded proteins
- [UPR](/entities/unfolded-protein-response) activation
- Apoptotic signaling in severe cases
Research Methods
Experimental Systems
- Knockout mice: Cbl conditional knockout in neurons
- Zebrafish models: Morpholino knockdown studies
- Cell culture: Neuronal differentiation of patient iPSCs
Detection Techniques
- Ubiquitination assays: In vitro ubiquitination
- RTK signaling: Phospho-RTK Western blots
- Neuronal morphology: Sholl analysis, dendritic branching
- Behavioral studies: Learning and memory testing
Therapeutic Approaches
Targeted Therapies
- MEK inhibitors: Address hyperactive RAS/MAPK pathway
- [mTOR](/mechanisms/mtor-signaling-pathway) inhibitors: Rapamycin for enhanced [autophagy](/entities/autophagy)
- JAK inhibitors: For myeloproliferation
Future Directions
- Gene therapy: Wild-type CBL delivery
- Protein stabilizers: Correct mutant protein folding
- Antisense oligonucleotides: Allele-specific silencing
Summary
CBL is a critical E3 ubiquitin ligase regulating receptor tyrosine kinase signaling in neurons and other cell types. While primarily known for its role in cancer and developmental disorders, CBL dysfunction can impact synaptic plasticity and neuronal homeostasis. Understanding CBL biology provides insights into neurodevelopmental disorders and potential therapeutic strategies.
Overview
Cbl Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Cbl Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Allen Brain Atlas Resources
Expression data for CBL in the human brain can be explored through the following Allen Brain Atlas resources:
- [Allen Human Brain Atlas - CBL Expression](https://human.brain-map.org/microarray/search/show?search_term=CBL): Gene expression data across brain regions
- [BrainSpan Atlas of the Developing Human Brain](https://brainspan.org/): Developmental expression patterns for CBL
External Links
- [NCBI Gene: CBL](https://www.ncbi.nlm.nih.gov/gene/867)
- [UniProt: CBL](https://www.uniprot.org/uniprot/P22681)
- [GeneCards: CBL](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CBL)
References
[Unknown, CBL mutations in Noonan syndrome-like disorder (2009) (2009)](https://pubmed.ncbi.nlm.nih.gov/19127353/)
[Unknown, CBL in receptor tyrosine kinase regulation (2008) (2008)](https://pubmed.ncbi.nlm.nih.gov/18337605/)
[Unknown, CBL syndrome: clinical features and genetics (2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/24478251/)
[Unknown, CBL ubiquitin ligase function and substrates (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/20026641/)
[Unknown, Neuronal CBL and synaptic plasticity (2013) (2013)](https://pubmed.ncbi.nlm.nih.gov/23665161/)
[Unknown, CBL and neurodevelopment (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/25914148/)
[Unknown, JMML and CBL mutations (2012) (2012)](https://pubmed.ncbi.nlm.nih.gov/22234939/)See Also
- [ACVR1 Gene](/wiki/genes-acvr1) — interacts_with
- [Gap Analysis & Research Strategy](/wiki/gaps-gap-analysis) — associated_with
- [Gap Analysis & Research Strategy](/wiki/gaps-gap-analysis) — inhibits
- [ad-sphingolipid-ceramide-companies](/wiki/companies-ad-sphingolipid-ceramide-companies) — causes
- [Apoptosis Pathway in Neurodegeneration](/wiki/mechanisms-apoptosis) — activates
Pathway Diagram
The following diagram shows the key molecular relationships involving CBL Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)